2004N-0355 - Scientific Considerations Related to Developing Biotechnology Products
  


  

  


  

  
FDA Comment Number : 
  

  
EC11
  



  

  

  



  

  
Submitter : 
  

  
Dr. Mathias Hukkelhoven
  

  
Date & Time: 
  

  
11/16/2004 06:11:04
  



  

  
Organization : 
  

  
Novartis Pharmaceuticals Corporation
  



  

  
Drug Industry
  


  

  
Category : 
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
See Attachment -- Comments Submitted On Behalf Of The Novartis Group Of Companies